PURPOSE: We examined breast nodules with three-dimensional (3D) sonography and power-Doppler to identify new parameters that might be useful in differentiating benign and malignant lesions. MATERIALS AND METHODS: Breast nodules in 34 women were examined with a Voluson-GE 730 scanner and a 7.5 MHz linear-array dedicated 3D probe. Each nodule was examined in the B-mode, and its vascular characteristics were evaluated with power-Doppler; 3D reconstruction was used in both studies. All examinations were performed by the same operator, who was unaware of the case characteristics. The examiner classified each lesion as benign or malignant based on B-mode appearance, margin characteristics, infiltration, and blood vessel distribution on power-Doppler; lesion volume was also calculated for T staging. Results were compared with those of biopsies, which were performed on all nodules after the sonographic examination. RESULTS: Biopsy findings revealed that 29 nodules were benign and 5 malignant. Based on the 3D sonographic examination, 27 lesions were considered benign, and 7 were classified as malignant. Two of the latter diagnoses were false-positives; there were no false negatives (specificity: 93.1%, sensitivity: 100%, accuracy: 94.1%). CONCLUSIONS: 3D sonography can be used to calculate lesional mass for T1 staging of malignant breast nodules. It can also reveal wall irregularities in benign lesions that are missed on two-dimensional (2D) scans and the limits of infiltration of malignant lesions. The 3D power-Doppler examination provides a panoramic full-length view of blood vessels supplying the nodule, and the number of vessels visualized with this approach is higher than that observed on 2D studies.
PURPOSE: We examined breast nodules with three-dimensional (3D) sonography and power-Doppler to identify new parameters that might be useful in differentiating benign and malignant lesions. MATERIALS AND METHODS: Breast nodules in 34 women were examined with a Voluson-GE 730 scanner and a 7.5 MHz linear-array dedicated 3D probe. Each nodule was examined in the B-mode, and its vascular characteristics were evaluated with power-Doppler; 3D reconstruction was used in both studies. All examinations were performed by the same operator, who was unaware of the case characteristics. The examiner classified each lesion as benign or malignant based on B-mode appearance, margin characteristics, infiltration, and blood vessel distribution on power-Doppler; lesion volume was also calculated for T staging. Results were compared with those of biopsies, which were performed on all nodules after the sonographic examination. RESULTS: Biopsy findings revealed that 29 nodules were benign and 5 malignant. Based on the 3D sonographic examination, 27 lesions were considered benign, and 7 were classified as malignant. Two of the latter diagnoses were false-positives; there were no false negatives (specificity: 93.1%, sensitivity: 100%, accuracy: 94.1%). CONCLUSIONS: 3D sonography can be used to calculate lesional mass for T1 staging of malignant breast nodules. It can also reveal wall irregularities in benign lesions that are missed on two-dimensional (2D) scans and the limits of infiltration of malignant lesions. The 3D power-Doppler examination provides a panoramic full-length view of blood vessels supplying the nodule, and the number of vessels visualized with this approach is higher than that observed on 2D studies.
Entities:
Keywords:
3D sonography; Breast nodules; Power-Doppler
Authors: G C Meyberg-Solomayer; B Kraemer; A Bergmann; E Kraemer; U Krainick; D Wallwiener; E-F Solomayer Journal: Ultrasound Med Biol Date: 2004-05 Impact factor: 2.998
Authors: Kyu Ran Cho; Bo Kyoung Seo; June Young Lee; Etta D Pisano; Bo Kyung Je; Ji Young Lee; Eun Jeong Choi; Kyoo Byung Chung; Yu Whan Oh Journal: Eur J Radiol Date: 2005-06 Impact factor: 3.528
Authors: Laura Liberman; Elizabeth A Morris; D David Dershaw; Andrea F Abramson; Lee K Tan Journal: AJR Am J Roentgenol Date: 2003-08 Impact factor: 3.959
Authors: Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod Journal: JAMA Date: 2004-09-15 Impact factor: 56.272